Skip to content

Clinical trials

Phase 1 Leukemia, Biphenotypic, Acute trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Biphenotypic, Acute Phase: Phase 1 Country / region: United States Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20023
20031
20043
20051
20073
20092
20102
20112
20121
20132
20142
20152
20173
20181
20192
20202
20213
20224
20233
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Recruiting9
Active, not recruiting9
Terminated6
Withdrawn2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)13
M.D. Anderson Cancer Center5
Fred Hutchinson Cancer Center4
Memorial Sloan Kettering Cancer Center4
Northwestern University3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
St. Jude Children's Research Hospital3
City of Hope Medical Center2
Ehab L Atallah2
University of Arizona2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Biphenotypic, Acute63
Precursor Cell Lymphoblastic Leukemia-Lymphoma48
Leukemia, Myeloid, Acute47
Myelodysplastic Syndromes27
Leukemia25
Leukemia, Lymphocytic, Chronic, B-Cell25
Burkitt Lymphoma24
Lymphoma, Non-Hodgkin24
Blast Crisis22
Leukemia, Myelomonocytic, Chronic22

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.